|
"moreno v"的相关文件
显示项目 1-8 / 8 (共1页)
1
每页显示[10|25|50]项目
| 臺大學術典藏 |
2022-09-15T01:08:52Z |
Ramucirumab and durvalumab for previously treated, advanced non–small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)
|
Bang Y.-J.; Golan T.; Dahan L.; Fu S.; Moreno V.; Park K.; Geva R.; De Braud F.; Wainberg Z.A.; Reck M.; Goff L.; Laing N.; Mi G.; Oliveira J.M.; Wasserstrom H.; Chia-Chi Lin |
| 臺大學術典藏 |
2022-09-15T01:08:45Z |
Safety and Antitumor Activity of a-PD-L1 Antibody as Monotherapy or in Combination witha-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient Tumors
|
Hollebecque A.; Chung H.C.; Miguel M.J.D.; Italiano A.; MacHiels J.-P.; Chia-Chi Lin; Dhani N.C.; Peeters M.; Moreno V.; Su W.-C.; Chow K.H.; Galvao V.R.; Carlse M.; Yu D.; Szpurka A.M.; Zhao Y.; Schmidt S.L.; Gandhi L.; Xu X.; Bang Y.-J. |
| 臺大學術典藏 |
2022-09-15T01:08:44Z |
First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma
|
Italiano A.; Cassier P.A.; Chia-Chi Lin; Alanko T.; Peltola K.J.; Gazzah A.; Shiah H.-S.; Calvo E.; Cervantes A.; Roda D.; Tosi D.; Gao B.; Millward M.; Warburton L.; Tanner M.; Englert S.; Lambert S.; Parikh A.; Afar D.E.; Vosganian G.; Moreno V. |
| 國立成功大學 |
2022 |
Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study
|
Simonelli, M.;Garralda, E.;Eskens, F.;Gil-Martin, Martin M.;Yen, C.-J.;Obermannova, R.;Chao, Y.;Lonardi, S.;Melichar, B.;Moreno, V.;Yu, M.-L.;Bongiovanni, A.;Calvo, E.;Rottey, S.;Machiels, J.-P.;Gonzalez-Martin, A.;Paz-Ares, L.;Chang, Chang C.-L.;Mason, W.;Lin, C.-C.;Reardon, D.A.;Vieito, M.;Santoro, A.;Meng, R.;Abbadessa, G.;Menas, F.;Lee, H.;Liu, Q.;Combeau, Combeau C.;Ternes, N.;Ziti-Ljajic, S.;Massard, C. |
| 臺大學術典藏 |
2021-09-06T03:18:02Z |
Investigating the genetic relationship between Alzheimer's disease and cancer using GWAS summary statistics
|
YEN-CHEN ANNE FENG; Cho K.; Lindstrom S.; Kraft P.; Cormack J.; Blalock K.; Campbell P.T.; Casey G.; Conti D.V.; Edlund C.K.; Figueiredo J.; James Gauderman W.; Gong J.; Green R.C.; Gruber S.B.; Harju J.F.; Harrison T.A.; Jacobs E.J.; Jenkins M.A.; Jiao S.; Li L.; Lin Y.; Manion F.J.; Moreno V.; Mukherjee B.; Peters U.; Raskin L.; Schumacher F.R.; Seminara D.; Severi G.; Stenzel S.L.; Thomas D.C.; Hopper J.L.; Southey M.C.; Makalic E.; Schmidt D.F.; Fletcher O.; Peto J.; Gibson L.; dos Santos Silva I.; Hunter D.J.; Ahsan H.; Whittemore A.; Waisfisz Q.; Meijers-Heijboer H.; Adank M.; van der Luijt R.B.; Uitterlinden A.G.; Hofman A.; Meindl A.; Schmutzler R.K.; M?ller-Myhsok B.; Lichtner P.; Nevanlinna H.; Muranen T.A.; Aittom?ki K.; Blomqvist C.; Chang-Claude J.; Hein R.; Dahmen N.; Beckman L.; Crisponi L.; Hall P.; Czene K.; Irwanto A.; Liu J.; Easton D.F.; Turnbull C.; Rahman N.; Kote-Jarai Z.; Muir K.; Giles G.; Neal D.; Donovan J.L.; Hamdy F.C.; Wiklund F.; Gronberg H.; Haiman C.; Travis R.; Riboli E.; Gapstur S.; Berndt S.; Chanock S.; Han Y.; Su L.; Wei Y.; Hung R.J.; Brhane Y.; McLaughlin J.; Brennan P.; McKay J.D.; Bickeb?ller H.; Rosenberger A.; Houlston R.S.; Caporaso N.; Landi M.T.; Heinrich J.; Risch A.; Wu X.; Ye Y.; Christiani D.C.; Amos C.I.; Liang L.; Driver J.A.; IGAP Consortium, Colorectal Transdisciplinary Study (CORECT), Discovery, Biology; Risk of Inherited Variants in Breast Cancer (DRIVE), Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE), Transdisciplinary Research in Cancer of the Lung (TRICL); YEN-CHEN ANNE FENG |
| 國家衛生研究院 |
2021-05 |
Phase I study of H3B-6527 in hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC)
|
Macarulla, T;Moreno, V;Chen, LT;Sawyer, MB;Goyal, L;Martin, AJM;Sheng-Shun, Y;Le Sourd, S;Morris, J;Fuchs, M;Karasic, TB;Kang, YK;Yong, WP;Selvaraj, A;Destenaves, B;Xiao, JA;Gomez, R;Gualberto, A;Pipas, JMM;Finn, RS |
| 國立成功大學 |
2021 |
Safety and Antitumor Activity of a-PD-L1 Antibody as Monotherapy or in Combination witha-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient Tumors
|
Hollebecque, A.;Chung, H.C.;Miguel, Miguel M.J.D.;Italiano, A.;MacHiels, J.-P.;Lin, C.-C.;Dhani, N.C.;Peeters, M.;Moreno, V.;Su, W.-C.;Chow, K.H.;Galvao, V.R.;Carlse, M.;Yu, D.;Szpurka, A.M.;Zhao, Y.;Schmidt, Schmidt S.L.;Gandhi, L.;Xu, Xu X.;Bang, Y.-J. |
| 臺大學術典藏 |
2020-05-25T07:35:09Z |
Safety and efficacy of the PD-1 inhibitor ABBV-181 in patients with advanced solid tumors: Preliminary phase I results from study M15-891
|
Powderly J; Cassier P.A; Cervantes A; Gao B; Gazzah A; Italiano A; Chia-Chi Lin; Luke J.J; Moreno V; Peltola K; Rasco D; Spira A.I; Tanner M.M.E; Tosi D; Afar D; Englert S; Parikh A; Reddy A; Vosganian G; Tolcher A.W. |
显示项目 1-8 / 8 (共1页)
1
每页显示[10|25|50]项目
|
